Company intelligence / Profile preview

Neurinnov

Montpellier, Occitanie, Franceneurinnov.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Preliminary clinical studies have demonstrated that Neurinnov’s implantable neurostimulation device can enable patients with complete tetraplegia to regain functional use of a hand, such as grasping objects or eating. In a published study, patients achieved stable voluntary control over paralyzed limbs for at least a month post-surgery without adverse effects or contradictory movements. Results have been published in peer-reviewed journals including Nature Scientific Reports.

Therapeutic areas: Neurology
Modalities: Device (Active implantable medical device)Neurostimulation technology
Industry: Implantable Medical Devices

Partnerships

Collaborations with INRIA and University of Montpellierpartnerships with research labs and medical institutions for R&D and clinical validation

Beyond the preview

Go deeper on Neurinnov.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurinnov.

Explore the full profile